|
A-D |
| Addressing health risks of noncoital sexual activity, #417 |
| Obstetrics and gynecology ; v. 112, no. 3:735-737, Sept. 2008 (Committee on Adolescent Health Care, Committee on Gynecologic Practice) |
|
|
| Advanced paternal age : risks to the fetus, #189 |
| International journal of gynecology and obstetrics ; v. 59, no. 3, Oct. 1997 (reaffirmed 2006, Committee on Genetics) |
|
|
| Age-related fertility decline, #413 |
| Obstetrics and gynecology ; v. 112, no. 2, pt. 1:409-411; Aug. 2008 (Committee on Gynecologic Practice) |
|
|
| Air travel during pregnancy, #264 |
| Obstetrics and gynecology ; v. 98, no. 6:1187-1188, Dec. 2001 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| Amnioinfusion does not prevent meconium aspiration syndrome, #346 |
| Obstetrics and gynecology ; v.108, no. 4:1053-1055, Oct. 2006 (Committee on Obstetric Practice) |
|
|
| Analgesia and Cesarean delivery rates, #269 |
| Obstetrics and gynecology ; v. 99, no. 2:369-370, Feb. 2002 (Committee on Obstetric Practice) |
|
|
| Androgen treatment of decreased libido, #244 |
| Obstetrics and gynecology ; v. 96, no. 5, Nov. 2000 (Committee on Gynecologic Practice) |
|
|
| Antenatal corticosteroid therapy for fetal maturation, #402 (replaces #273) |
| Obstetrics and gynecology ; v. 111, no. 3:805-807; March 2008 (Committee on Obstetric Practice) |
|
|
| Antibiotic prophylaxis for infective endocarditis, #421 (replaces Practice Bulletin #47) |
| Obstetrics and gynecology ; v. 112, no. 5:1193-1194; Nov. 2008 (Committee on Obstetric Practice) |
|
|
| Apgar score, #333 (replaces #174) |
| Obstetrics and gynecology ; v. 107:no.5, 1209-1212, May 2006 (Committee on Obstetric Practice) |
|
|
| Appropriate use of laparoscopically assisted vaginal hysterectomy, #311 |
| Obstetrics and gynecology ; v.105, no. 4:929-930, Apr. 2005 (Committee on Gynecologic Practice) |
|
|
| Aromatase inhibitors in gynecologic practice, #412 |
| Obstetrics and gynecology ; v. 112, no. 2, pt. 1:405-407; Aug. 2008 (Committee on Gynecologic Practice) |
|
|
| At-risk drinking and illicit drug use: ethical questions in obstetric and gynecologic practice, #422 (replaces #294) |
| Obstetrics and gynecology ; v. 112, no. 6:1449-1460; Dec. 2008 (Committee on Ethics) |
|
|
| Avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test results, #278 |
| Obstetrics and gynecology ; v. 100, no. 5:1057-1059, Nov. 2002 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Bone density screening for osteoporosis, #270 |
| Obstetrics and gynecology ; v. 99, no. 3:523-525, Mar.2002 (Committee on Gynecologic Practice) |
|
|
| Brand versus generic oral contraceptives, #375 |
| Obstetrics and gynecology ; v. 110, no. 2, pt. 1:447-448; Aug. 2007 (Committee on Gynecologic Practice) |
|
|
| Breast concerns in the adolescent, #350 |
| Obstetrics and gynecology ; v.108, no.5:1329-1336, Nov. 2006 (Committee on Adolescent Health Care) |
|
|
| Breastfeeding: maternal and infant aspects, #361 |
| Obstetrics and gynecology ; v. 109, no. 2, part 1:479-480, Feb. 2007 (Committee on Health Care for Underserved Women and Committee on Obstetric Practice) |
|
|
| Breast-ovarian cancer screening, #239 |
| Obstetrics and gynecology ; v. 96, no. 2, Aug. 2000 (Committee on Genetics) |
|
|
| Cesarean delivery on maternal request, #394 (replaces 386) |
| Obstetrics and gynecology ; v. 110, no. 6:1501-1504; Dec. 2007(Committee on Obstetric Practice) |
|
|
| Cervical cancer screening in adolescents, #300 |
| Obstetrics and gynecology ; v. 104, no. 4:885-889, Oct. 2004 (Committee on Adolescent Health Care) |
|
|
| Cervical cytology screening, #2 (Technology assessment) |
| Obstetrics and gynecology ; v. 100, no. 6:1423-1427, Dec. 2002 (Committee on Gynecologic Practice) |
|
|
| Circumcision, #260 |
| Obstetrics and gynecology ; v. 98, no. 4:707-708, Oct. 2001 (Committee on Obstetric Practice) |
|
|
| Coding responsibility, #249 |
| Obstetrics and gynecology ; v. 97, no. 1, Aug. 1998 (reaffirmed 2005, Committee on Coding and Nomenclature) |
|
|
| Colonoscopy and colorectal cancer screening and prevention, #384 |
| Obstetrics and gynecology ; v. 100, no.5:1199-1202; Nov. 2007 (Committee on Gynecologic Practice) |
|
|
| Commercial enterprises in medical practice, #359 (update of Commercial enterprises in medical practice in Ethics in Obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 109, no.1:243-245, Jan. 2007 (Committee on Ethics) |
|
|
| Coping with the stress of medical professional liability litigation, #406 (replaces #309) |
| Obstetrics and gynecology ; v. 111, no. 5:1257-1258; May 2008 (Committee on Professional Liability) |
|
|
| Complementary and alternative medicine, #227 |
| Obstetrics and gynecology ; v. 94, no. 5, Nov. 1999 (reaffirmed 2004, Committee on Primary Care) |
|
|
| Compounded Bioidentical Hormones, #322 |
| Obstetrics and Gynecology ; v. 106, no. 5: 1139-1140, Nov. 2005 (Committee on Gynecologic Practice) |
|
|
| Depot medroxyprogesterone acetate and bone effects, #415 |
| Obstetrics and gynecology ; v. 112, no. 3:727-734; Sept. 2008 (Committee on Adolescent Health Care, Committee on Gynecologic Practice) |
|
|
| Direct-to-consumer marketing of genetic testing, #409 |
| Obstetrics and gynecology ; v. 111, no. 6:1493-1494: June 2008 (Committee on Genetics, Committee on Ethics) |
|
|
| Disclosure and discussion of adverse events, #380 |
| Obstetrics and gynecology ; v. 110, no. 4:957-958; Oct. 2007 (Committee on Patient Safety and Quality Improvement, Committee on Professional Liability) |
|
|
| Disruptive behavior, #366 |
| Obstetrics and gynecology ; v. 109, no. 5: 1261-1262, May 2007 (Committee on Patient Safety and Quality Improvement) |
|
|
| "Do not use" abbreviations, #327 |
| Obstetrics and gynecology ; v. 107, no. 1 :213-214, Jan 2006 (Committee on Quality Improvement and Patient Safety) |
|
|
|
E-H |
| Elective Coincidental Appendectomy, #323 (replaces #164) |
| Obstetrics and Gynecology ; v. 106, no. 5: 1141-1142 Nov. 2005 (Committee on Gynecologic Practice) |
|
|
| End-of-life decision making, #403 (update of "End-of-life deicions making" in Ethics in Obstetrics and Gynecology, 2nd ed., 2004) |
| Obstetrics & gynecology ; v. 111, no. 4:1021-1027: April 2008. (Committee on Ethics) |
|
|
| Endometriosis in adolescents, #310 |
| Obstetrics and gynecology ; v.105, no. 4:921-927, Apr. 2005 (Committee on Adolescent Health Care) |
|
|
| Ethical considerations in research involving women, #290 |
| Obstetrics and gynecology ; v.102, no. 5:1107-1113, Nov. 2003 (Committee on Ethics) |
|
|
| Ethical decision making in obstetrics and gynecology, #390 (update of "Ethical decision making in obstetrics and gynecology" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 110, no. 6:1479-1487; Dec. 2007. |
|
|
| Ethical issues in genetic testing, #410 |
| Obstetrics & gynecology ; v. 111, no. 6:1495-1502; June 2008. (Committee on Ethics, Committee on Genetics) |
|
|
| Ethical ways for physicians to market a practice, #341 |
| Obstetrics and gynecology ; v.108, no.1:239-242, July 2006 (Committee on Ethics) |
|
|
| Evaluation and management of abnormal cervical cytology and histology in the adolescent, #330 |
| Obstetrics and gynecology ; v.107, no. 4:963-968, Apr. 2006 (Committee on Adolescent Health Care) |
|
|
| Evaluation of stillbirths and neonatal deaths, #383 (replaces #257) |
| Obstetrics and gynecology ; v. 100, no. 4:963-966; Oct. 2007 (Committee on Genetics) |
|
|
| Exercise during pregnancy and the postpartum period, #267 |
| Obstetrics and gynecology ; v. 99, no. 1:171-173, Jan. 2002 (reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Expert testimony, #374 (update of "Expert testimony" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 110, no. 2, pt. 1:445-446; Aug. 2007 (Committee on Ethics) |
|
|
| Fatigue and patient safety, #398 |
| Obstetrics and gynecology ; v. 111, no. 2, pt. 2:471-473; Feb. 2008 (Committee on Patient Safety and Quality Improvement) |
|
|
| Fetal monitoring prior to scheduled cesarean delivery, #382 |
| Obstetrics and gynecology ; v. 110, no. 4:961-2; Oct. 2007. (Committee on Obstetric Practice) |
|
|
| Fetal pulse oximetry, #258 |
| Obstetrics and gynecology ; v. 98, no. 3:523-24, Sept. 2001 (reaffirmed 2004, Committee on Obstetric Practice) |
|
|
| Fetal surgery for open neural tube defects, #252 |
| Obstetrics and gynecology ; v. 97, no. 3, Mar. 2001 (Committee on Obstetric Practice) |
|
|
| First-trimester screening for fetal aneuploidy, #296 (replaces #223) |
| Obstetrics and gynecology ; v. 104, no. 1, July 2004 (Committee on Obstetric Practice, Committee on Genetics) |
|
|
| Follow-up of abnormal screening mammography, #272 |
| Obstetrics and gynecology ; v. 99, no. 5:869, May 2002 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Fragile X syndrome, #161 |
| International journal of gynecology and obstetrics ; v. 52, no. 2, Oct. 1995 (reaffirmed 2000, Committee on Genetics) |
|
|
| Genetic screening of gamete donors, #192 |
| International journal of gynecology and obstetrics ; v. 60, no. 2, Oct. 1997 (reaffirmed 1999, 2001, Committee on Genetics) |
|
|
| Genetics and molecular diagnostic testing, #1 (Technology assessment) |
| Obstetrics and gynecology ; v. 100, no.1:193-211, July 2002 (reaffirmed 2006, Committee on Genetics) |
|
|
| Guidelines for adolescent health research, #302 |
| Obstetrics and gynecology ; v. 104, no. 4:899-902, Oct. 2004 (Committee on Adolescent Health Care) |
|
|
| Guidelines for diagnostic imaging during pregnancy, #299 (replaces #158) |
| Obstetrics and gynecology ; v. 104, no.3:647-651, Sept. 2004 (Committee on Obstetric Practice) |
|
|
| Health care for homeless women, #312 |
| Obstetrics and gynecology ; v.106, no. 2:429-434, Aug. 2005 (Committee on Health Care for Underserved Women) |
|
|
| Health literacy, #391 |
| Obstetrics and gynecology ; v. 100, no. 6:1489-1491; Dec. 2007 (Committee on Health Care for Underserved Women) |
|
|
| Hepatitis B and Hepatitis C virus infections in obstetrician-gynecologists, #332 (replaces #203) |
| Obstetrics and gynecology ; v.107:no.5, May 2006:1207-1208 (Committee on Gynecologic Practice) |
|
|
| Hormone replacement therapy in women treated for endometrial cancer, #235 |
| Obstetrics and gynecology ; v. 95, no. 5, May 2000 (reaffirmed 2001, Committee on Gynecologic Practice) |
|
|
| Hormone replacement therapy in women with previously treated breast cancer, #226 |
| Obstetrics and gynecology ; v. 94, no. 5, Nov. 1999 (reaffirmed 2001, Committee on Gynecologic Practice) |
|
|
| Hormone therapy and heart disease, #420 |
| Obstetrics and gynecology ; v. 112, no. 5:1189-1192; Nov. 2008. (Committee on Gynecologic Practice) |
|
|
| Human immunodeficiency virus, #389 (update of "Human immunodeficiency virus" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 100, no. 6:1473-1478; Dec. 2007 (Committee on Ethics) |
|
|
| Human immunodeficiency virus and acquired immunodeficiency syndrome and women of color, #414 |
| Obstetrics and gynecology ; v. 112, no. 2, pt. 1:413-416; Aug. 2008. (Committee on Health Care for Underserved Women) |
|
|
| Human papillomavirus vaccination, #344 |
| Obstetrics and gynecology ; v.108, no.3, part 1:699-704, Sept. 2006 (Committee on Adolescent Health Care and The ACOG Working Group on Immunization) |
|
|
| Hysteroscopy, #4 (Technology assessment) |
| Obstetrics and gynecology ; v.106, no. 2:439-442, Aug. 2005 |
|
|
| Immunization during pregnancy, #282 |
| Obstetrics and gynecology ; v. 101, no. :207-212, Jan. 2003 (reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Importance of preconception care in the continuum of women's health care, #313 |
| Obstetrics and gynecology ; v.106, no. 3:665-666, Sep. 2005 (Committee on Gynecologic Practice) |
|
|
| Inappropriate reimbursement practices by third-party payers, #250 |
| Obstetrics and gynecology ; v. 97, no. 1, Jan. 2001 (Committee on Coding and Nomenclature) |
|
|
| Inappropriate use of the terms fetal distress and birth asphyxia, #326 (replaces #303) |
| Obstetrics and gynecology ; v. 106, no. 6: 1469-1470, December 2005 (Committee on Obstetric Practice) |
|
|
| Induced abortion and breast cancer risk, #285 |
| Obstetrics and gynecology ; v. 102, no. 2:433-435, Aug. 2003 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Induction of labor for vaginal birth after Cesarean delivery, #342 |
| Obstetrics and gynecology ; v. 108, no. 2:465-467, Aug. 2006 (replaces #271, Committee on Obstetric Practice) |
|
|
| Induction of labor with misoprostol, #228 |
| Obstetrics and gynecology ; v. 94, no. 5, Nov. 1999 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| Influenza vaccination and treatment during pregnancy, #305 |
| Obstetrics and gynecology ; v. 104, no. 5:1125-1126, Nov. 2004 (Committee on Obstetric Practice) |
|
|
| Informed refusal, #237 |
| Obstetrics and gynecology ; v. 95, no. 6, June 2000 (Committee on Professional Liability) |
|
|
| Initial reproductive health visit, #335 |
| Obstetrics and gynecology ; v.107:no.5, May 2006:1215-1218 (Committee on Adolescent Health) |
|
|
| Innovative practice: ethical guidelines, #352 |
| Obstetrics and gynecology ; v.108, no.6:1589-1595, Dec. 2006 (Committee on Ethics) |
|
|
| Institutional responsibility to provide legal representation, #370 (update of "Institutional responsibility to provide legal representation" in Ethics and obstetrics and gynecology, 2nd ed., 2004.) |
| Obstetrics and gynecology ; v. 110, no. 1, July 2007 (Committee on Ethics) |
|
|
| Intraperitoneal chemotherapy for ovarian cancer, #396 |
| Obstetrics and gynecology ; v. 111, no. 1:249-251; Jan. 2008. (Committee on Gynecologic Practice) |
|
|
| Intrauterine device and adolescents, #392 |
| Obstetrics and gynecology ; v. 110, no. 6:1493-1495; Dec. 2007. (Committee on Adolescent Health Care) |
|
|
| Late-preterm infants, #404 |
| Obstetrics and gynecology ; v. 111, no. 4:1029-1032; April 2008. (Committee on Obstetric Practice) |
|
|
| The Limits of conscientious refusal in reproductive medicine, #385 |
| Obstetrics and gynecology ; v. 110, no. 5: 1203-1208; Nov. 2007 (Committee on Ethics) |
|
|
| Low bone mass (osteopenia) and fracture risk, #407 |
| Obstetrics and gynecology ; v. 111, no. 5: 1259-1261; May 2008 (Committee on Gynecologic Practice) |
|
|
| Management of asymptomatic pregnant or lactating women exposed to anthrax, #268 |
| Obstetrics and Gynecology ; v. 99, no. 2:366-368, Feb. 2002 (reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Maternal decision making, ethics, and the law, #321 |
| Obstetrics and gynecology ; v. 106, no. 5: 1127-1137, Nov. 2005 (Committee on Ethics) |
|
|
| Management of delivery of a newborn with meconium-stained amniotic fluid, #379 |
| Obstetrics and gynecology ; v. 110, no. 3: 739; Sept. 2007 (Committee on Obstetric Practice) |
|
|
| Maternal phenylketonuria, #230 |
| Obstetrics and gynecology ; v. 95, no. 1, Jan. 2000 (reaffirmed 2004, Committee on Genetics) |
|
|
| Medical emergency procedures, #353 |
| Obstetrics and gynecology ; v.108, no.6:1597-1599, Dec. 2006 (Committee on Patient Safety and Quality Improvement) |
|
|
| Medical futility, #362 (Update of "Medical futility", in Ethics in obstetrics and gynecology, 2nd ed., 2004. |
| Obstetrics and gynecology, v. 109, no.3, Mar. 2007 (Committee on Ethics) |
|
|
| Meningococcal vaccination for adolescents, #314 |
| Obstetrics and gynecology ; v.106, no. 3:667-669, Sep. 2005 (Committee on Adolescent Health Care) |
|
|
| Menstruation in girls and adolescents: using the menstrual cycle as a vital sign, #349 |
| Obstetrics and gynecology ; v.108, no. 5:1323-1328, Nov. 2006 (Committee on Adolescent Health Care) |
|
|
| Mifepristone for medical pregnancy termination, #245 |
| Obstetrician and gynecology ; v. 96, no. 6, Dec. 2000 (reaffirmed 2003, Committee on Gynecologic Practice) |
|
|
| Mode of term singleton breech delivery, #340 |
| Obstetrics and gynecology ; v. 108, no. 1:235-237, July 2006 (replaces #265, Committee on Obstetric Practice) |
|
|
| Nalbuphine hydrochloride use for intrapartum analgesia, #376 |
| Obstetrics and gynecology ; v. 110, no. 2, pt. 1:449; Aug. 2007 (Committee on Obstetric Practice) |
|
|
| New U. S. Food and Drug Administration labeling on Cytotec (Misoprostol) use and pregnancy, #283 |
| Obstetrics and gynecology ; v.101, no. 5, pt. 1:1049-1050, May 2003 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| New ultrasound output display standard, #180 |
| International journal of gynecology and obstetrics ; v. 57, no. 2, Nov. 1996 (reaffirmed 2002, Committee on Obstetric Practice) |
|
|
| Newborn screening, #393 (replaces #287) |
| Obstetrics and gynecology ; v. 110, no. 6:1497-1500; Dec. 2007 (Committee on Genetics) |
|
|
| Nongynecologic procedures, #253 |
| Obstetrics and gynecology ; v. 97, no. 3, Mar 2001 (reaffirmed 2006, Committee on Gynecologic Practice) |
|
|
| Nonmedical use of obstetric ultrasonography, #297 |
| Obstetrics and gynecology ; v. 104, no. 2:423-424, Aug. 2004 (Committee on Ethics) |
|
|
| Nonobstetric surgery in pregnancy, #284 |
| Obstetrics and gynecology ; v. 102, no. 2:431, Aug. 2003 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| Nonsurgical diagnosis and management of vaginal agenesis, #355 |
| Obstetrics and gynecology ; v. 108, no. 6:1605-1609, Dec. 2006 (replaces #274, Committee on Adolescent Health Care) |
|
|
| Obesity in pregnancy, #315 |
| Obstetrics and gynecology ; v.106, no. 3:671-675, Sep. 2005 (Committee on Obstetric Practice) |
|
|
| Obstetric management of patients with spinal cord injuries, #275 |
| Obstetrics and gynecology ; v. 100, no. 3:625-627, Sept. 2002 (replaces #121, reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Optimal goals for anesthesia care in obstetrics, #256 |
| Obstetrics and gynecology ; v. 97, no. 5, May 2001 (reaffirmed 2006, Committee on Obstetric Practice with the American Society of Anesthesiologists Committee on Obstetric Anesthesia) |
|
|
| Ovarian tissue and oocyte cryopreservation, #405 |
| Obstetrics and gynecology ; v. 111, no. 5: 1255-1256; May 2008 (Committee on Gynecologic Practice) |
|
|
| The Overweight adolescent: prevention, treatment, and obstetric-gynecologic implications, #351 |
| Obstetrics & gynecology ; v.108, no.5:1337-1347, Nov. 2006 (Committee on Adolescent Health Care) |
|
|
|
P-S |
| Pain relief during labor, #295 |
| Obstetrics and gynecology ; v. 104, no. 1, July 2004 (replaces #231, reaffirmed 2006, Committee on Obstetric Practice with American Society of Anesthesiologists) |
|
|
| Partnering with Patients to Improve Safety, #320 ( |
| Obstetrics and gynecology ; v. 106, no. 5:1123-1125, Nov. 2005 (Committee on Quality Improvement and Patient Safety) |
|
|
| Patents, medicine, and the interests of patients, #364 (Update of "Patents, medicine and the interests of patients" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 109, no. 5: 1249-1253 (Committees on Ethics and Genetics) |
|
|
| Patents, medicine, and the interests of patients: applying general principles to gene patenting, #277 |
| Obstetrics and gynecology ; v. 100, no. 5:1051-1056, Nov. 2002 (Committee on Ethics, Committee on Genetics) |
|
|
| Patient safety in obstetrics and gynecology, #286 |
| Obstetrics and gynecology ; v. 102, no. 4:883-885, Oct. 2003 (reaffirmed 2006, Committee on Quality Improvement and Patient Safety) |
|
|
| Patient safety in the surgical environment, #328 |
| Obstetrics and gynecology ; v. 1072, no. 2, pt.1:429-433, Feb. 2006 (Committee on Quality Improvement and Patient Safety) |
|
|
| Patient testing: ethical issues in selection and counseling, #363 |
| Obstetrics and gynecology ; v. 109, no. 4: 1021-1023, Apr. 2007 (Committee on Ethics) |
|
|
| Performance and interpretation of imaging studies by obstetrician-gynecologists, #243 |
| Obstetrics and gynecology ; v. 96, no. 5, Nov. 2000 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Perinatal Risks Associated with Assisted Reporductive Technology, #324 |
| Obstetrics and Gynecology ; v. 106, no. 5: 1143-1146, Nov. 2005 (Committee on Obstetric Practice, Committee on Gynecologic Practice, Committee on Genetics) |
|
|
| Pharmaceutical compounding, #387 |
| Obstetrics and gynecology ; v. 110, no. 5: 1213-4; Nov. 2007 (Committee on Gynecologic Practice) |
|
|
| Placental pathology, #125 |
| International journal of gynecology and obstetrics ; v. 42, no. 3, June 1993 (reaffirmed 2006, Committee on Obstetric Care) |
|
|
| Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations, #418 (replaces #304) |
| Obstetrics and gynecology ; v. 112, no. 3:739-742; Sept. 2008 (Committee on Obstetric Practice) |
|
|
| Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent, #298 |
| Obsterics and gynecology ; v. 104, no. 2:425-428, Aug. 2004 (reaffirmed 2006, Committee on Genetics) |
|
|
| Prevention of early-onset Group B streptococcal disease in newborns, #279 |
| Obstetrics and gynecology ; v. 100, no. 6:1405-1412, Dec. 2002 (replaces #173, reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Primary and preventive care : periodic assessments, #357 |
| Obstetrics and gynecology ; v. 108, no. 6:1615-1622, Dec. 2006 (replaces #292, Committee on Gynecologic Practice) |
|
|
| Professional liability and gynecology-only practice, #408 (replaces #288) |
| Obstetrics and gynecology ; v. 111, no. 6: 1491; June 2008 (Committee on Gynecologic Practice, Committee on on Obstetric Practice, Committee on Professional Liability) |
|
|
| Professional responsibilities in obstetric-gynecologic education, #358 (Update of "Obstetric-Gynecologic Education" in Ethics in Obstetrics and Gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 109, no. 1:239-242, Jan. 2007 (Committee on Ethics) |
|
|
| Psychosocial risk factors: perinatal screening and intervention, #343 |
| Obstetrics and gynecology ; v.108, no. 2: 469-477, Aug. 2006 (Committee on Health Care for Underserved Women) |
|
|
| Racial and ethnic disparities in women's health, #317 |
| Obstetrics and gynecology ; v.106, no. 4:889-892, Oct. 2005 (Committee on Health Care for Underserved Women) |
|
|
| Recommendations on frequency of Pap test screening, #152 |
| International journal of gynecology and obstetrics ; v. 49, no. 2, Mar. 1995 (reaffirmed 1998, Committee on Gynecologic Practice) |
|
|
| Relationships with industry, #401 (update of "Relationships with industry" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 111, no. 3: 799-804; March 2008 (Committee on Ethics) |
|
|
| Research involving women (update of "Research involving women" in Ethics in obstetrics and gynecology, 2nd ed, 2004) |
| Obstetrics and gynecology ; v. 110, no. 3: 731-736; Sept. 2007 (Committee on Ethics) |
|
|
| Response to Searle's drug warning on misoprostol, #248 |
| Obstetrics and gynecology ; v. 96, no. 6, Dec. 2000 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| Risk of breast cancer with estrogen-progestin replacement therapy, #262 |
| Obstetrics and gynecology ; v. 98, no. 6, Dec. 2001 (Committee on Gynecologic Practice) |
|
|
| The Role of cystourethroscopy in the generalist obstetrician-gynecologist practice, #372 |
| Obstetrics and gynecology, v. 110, no. 1: 221-224, July 2007 (Committee on Gynecologic Practice) |
|
|
| Role of loop electrosurgical excision procedure in the evaluation of abnormal Pap test results, #195 |
| International journal of gynecology and obstetrics ; v. 61, no. 2, Nov. 1997 (reaffirmed 2000, Committee on Gynecologic Practice) |
|
|
| Role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer, #280 |
| Obstetrics and gynecology ; v. 100, no. 6:1413-1416, Dec. 2002 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Role of the obstetrician-gynecologist in the assessment and management of obesity, #319 |
| Obstetrics and gynecology ; v. 106, no. 4:895-899, Oct. 2005 (Committee on Gynecologic Practice) |
|
|
| Role of the obstetrician-gynecologist in the screening and diagnosis of breast masses, #334 (Replaces #186) |
| Obstetrics and gynecology ; v. 107, no. 5:1213-1214, May 2006 (Committee on Gynecologic Practice) |
|
|
| Routine cancer screening, #356 |
| Obstetrician and gynecology ; v. 108, no. 6:1611-1613, Dec. 2006 (Committee on Gynecologic Practice) |
|
|
| Routine human immunodeficiency virus screening, #411 |
| Obstetrics and gynecology ; v. 112, no. 2, pt. 1: 401-403; Aug. 2008 (Committee on Gynecologic Practice) |
|
|
| Routine storage of umbilical cord blood for potential future transplantation, #183 |
| International journal of gynecology and obstetrics ; v. 58, no. 2, Apr. 1997 (reaffirmed 2004, Committee on Genetics with Committee on Obstetric Practice) |
|
|
| Rubella vaccination, #281 |
| Obstetrics and gynecology ; v. 100, no. 6:1417, Dec. 2002 (reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Safe use of medication, #331 |
| Obstetrics and gynecology ; v.107, no. 4:969-972, Apr. 2006 (Committee on Quality Improvement and Patient Safety) |
|
|
| Safety of Lovenox in pregnancy, #276 |
| Obstetrics and gynecology ; v. 100, no. 4:845-846, Oct. 2002 (reaffirmed 2005, Committee on Obstetric Practice) |
|
|
| Saline infusion sonohysterography, #3 (Technology assessment) |
| Obstetrics and gynecology ; vo. 102, no. 3:659-662, Sep. 2003 (reaffirmed 2005, Committee on Gynecologic Practice) |
|
|
| Scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection, #234 |
| Obstetrics and gynecology ; v. 95, no. 5, May 2000 (reaffirmed 2006, Committee on Obstetric Practice) |
|
|
| Screening for Canavan Disease, #212 |
| Obstetrics and gynecology ; v. 92, no. 5, Nov. 1998 (reaffirmed 2004, Committee on Genetics) |
|
|
| Screening for Tay-Sachs disease, #318 |
| Obstetrics and gynecology; v. 106, no. 4:893-894, Oct. 2005 (replaces #162) (Committee on Genetics) |
|
|
| Seeking and giving consultation, #365 (Update of "Seeking and giving consultation" in Ethics in obstetrics and gynecology, 2nd ed., 2004. |
| Obstetrics and gynecology; v. 109, no. 5: 1255-1257, May 2007 (Committee on Ethics) |
|
|
| Sex selection, # 360 (Update of "Sex Selection," in Ethics in Obstetrics and Gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 109, no. 2, part 1:475-478, Feb. 2007 (Committee on Ethics) |
|
|
| Sexual Misconduct, #373 (update of "Sexual Misconduct" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 110, no. 2, pt. 1: 441-444; Aug. 2007 (Committee on Ethics) |
|
|
| Sexually transmitted diseases in adolescents, #301 |
| Obstetrics and gynecology ; v. 104, no. 4:891-898, Oct. 2004 (Committee on Adolescent Health Care) |
|
|
| Smoking cessation during pregnancy, #316 (replaces Education Bulletin #260) |
| Obstetrics and gynecology ; v. 106, no. 4:883-888, Oct. 2005 (reaffirmed 2004, Committee on Health Care for Underserved Women, Committee on Obstetric Practice) |
|
|
| Statement on surgical assistants, #240 |
| Obstetrics and gynecology ; v. 96, no. 2, Aug. 2000 (reaffirmed 2006, Committee on Gynecologic Practice with Committee on Obstetric Practice) |
|
|
| Sterilization of women, including those with mental disabilities (Update of "Sterilization of women, including those with mental disabilities" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology, v. 110, no. 1:217-220, July 2007 (Committee on Ethics) |
|
|
| Subclinical hypothyroidism in pregnancy, #381 |
| Obstetrics and gynecology ; v. 110, no. 4: 959-960; Oct. 2007 (Committee on Obstetric Practice) |
|
|
| Supracervial hysterectomy, #388 |
| Obstetrics and gynecology ; v. 110, no. 5: 1215-127; Nov. 2007 (Committee on Gynecologic Practice) |
|
|
| Surgery and patient choice, #395 (update of "Surgery and patient choice" in Ethics in obstetrics and gynecology, 2nd ed., 2004) |
| Obstetrics and gynecology ; v. 111, no. 1: 243-247; Jan. 2008 (Committee on Ethics) |
|
|
| Surrogate motherhood, #397 (update of "Surrogate motherhood" in Ethics in obstetrics and gynecology, 2nd ed., 2007) |
| Obstetrics and gynecology ; v. 111, no. 2, pt. 1: 465-470; Feb. 2008 (Committee on Ethics) |
|
|